CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
26. Februar 2025 08:00 ET
|
CG Oncology Inc.
CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Cardiff Oncology to Present at Upcoming Investor Conferences
24. Februar 2025 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Coherus Management to Present at the TD Cowen 5th Annual Oncology Innovation Virtual Summit: Insights for ASCO & EHA
23. Mai 2024 09:00 ET
|
Coherus BioSciences, Inc.
REDWOOD CITY, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS) today announced that senior management will present at the upcoming TD Cowen 5th Annual...
Cardiff Oncology to Present at Upcoming Investor Conferences in May
13. Mai 2024 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
Immuneering to Participate in the Cowen 44th Annual Health Care Conference
04. März 2024 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal-RAS/RAF medicines for...
uniQure to Participate in Multiple Upcoming Industry Conferences in March
02. März 2023 07:05 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, March 02, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
01. März 2023 06:00 ET
|
Evelo Biosciences, Inc.
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered anti-inflammatory...
Surface Oncology to Participate in the Cowen 43rd Annual Health Care Conference
28. Februar 2023 16:15 ET
|
Surface Oncology, Inc.
CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor...
Icosavax to Participate in the Upcoming Healthcare Conferences
28. Februar 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Exagen Inc. to Participate in Upcoming March Conferences
27. Februar 2023 09:00 ET
|
Exagen Inc.
SAN DIEGO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following March...